Mercado cerrado

HealthEquity, Inc HQY

USD103,45

hoy

HQY es la acción de HealthEquity, Inc. Cotiza a USD 103,45. Puedes invertir en HQY desde Chile con Racional, en dólares, sin comisión por transacción y desde CLP 5.000.

Invierte en HealthEquity, Inc con Racional.

Racional te permite invertir en fondos indexados de bajo costo y +10.000 acciones de EE.UU. Comienza con solo CLP 5.000, en menos de 5 minutos.

Crear cuentaSúmate a más de 150.000 personas invirtiendo.

Descripción HealthEquity, Inc

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Sitio web

AperturaUSD 103,88

Cierre previoUSD 103,05

Rango del díaUSD 102,58 – USD 104,01

Rango 52 sem.USD 73,21 – USD 108,84

Volumen0,6 M

Acciones en circulación82,7 M

CapitalizaciónUSD 8.524 M

Precio/utilidad (P/E)36,04

Utilidad por acciónUSD 2,86

Empleados2.814

En bolsa desde2014

HQY es la acción de HealthEquity, Inc y cotiza en bolsa desde 2014. Su rentabilidad es de +53,62% en los últimos 5 años, +3,96% en el último año, +15,11% en el último mes y +0,38% hoy. Datos al 15 de noviembre de 2026.

Rentabilidad por período

PeríodoHQY

1 día

MTD

1 mes

YTD

1 año

5 años9,0% anual

Resultados financieros

Ingresos 2026

USD 1.313 M

vs 2025

Utilidad neta 2026

USD 215 M

vs 2025

Flujo operacional 2026

USD 457 M

vs 2025

IngresosUtilidad neta

2022

Margen -5,9%

2023

Margen -3,0%

2024

Margen 5,6%

2025

Margen 8,1%

2026

Margen 16,4%

Noticias

Zacks Investment Research 12 nov
Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates
Prime Medicine (PRME) reported a quarterly loss of $0.22 per share, beating consensus estimates of $0.23 loss by 4.35%, but missed revenue expectations with $4.21 million versus the consensus estimate, down 25.8%. The stock has outperformed the S&P 500 by 12.6% year-to-date but carries a Zacks Rank #3 (Hold) rating with mixed estimate revisions.
Zacks Investment Research 5 nov
CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
CryoPort (CYRX) reported a quarterly loss of $0.25 per share, missing the consensus estimate of $0.19 loss by 31.58%. However, the company exceeded revenue expectations with $50.22 million versus the estimate of $48.68 million. The stock has gained 74% year-to-date but received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.
Zacks Investment Research 3 nov
BLCO vs. HQY: Which Stock Is the Better Value Option?
A comparison of two Medical Services stocks shows that Bausch + Lomb (BLCO) is more attractive for value investors than HealthEquity (HQY). BLCO has a stronger Zacks Rank of #1 (Strong Buy) versus HQY's #2 (Buy), and superior valuation metrics including a lower forward P/E ratio (21.20 vs 21.96), a significantly better PEG ratio (0.53 vs 1.36), and a lower P/B ratio (1.1 vs 4.31), earning it a Value grade of B compared to HQY's C grade.
Zacks Investment Research 28 oct
Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"
HealthEquity (HQY) is highlighted as a compelling growth stock investment opportunity, featuring a Growth Score of B and Zacks Rank #2. The company demonstrates strong fundamentals including 18% projected EPS growth (above the 14% industry average), robust year-over-year cash flow growth of 22%, and positive earnings estimate revisions, positioning it as a potential outperformer for growth investors.
Zacks Investment Research 15 oct
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
HealthEquity (HQY), a healthcare account management solutions provider, is highlighted as a potential growth investment pick. The company holds a #3 (Hold) Zacks Rank with a B VGM Score and B Growth Style Score, forecasting 18% year-over-year earnings growth. Two analysts recently raised earnings estimates, with the consensus estimate increasing to $4.72 per share, and the company demonstrates an average earnings surprise of +8.7%.

Regístrate para leer las noticias

Preguntas frecuentes sobre HQY

¿Cómo invertir en HQY desde Chile?

Crea tu cuenta en Racional en minutos, deposita desde CLP 5.000, busca HQY y compra en dólares. No pagas comisión por transacción y puedes hacerlo desde la app o la web.

¿Cuál es el precio de HQY hoy?

Al 15 de noviembre de 2026, HQY cotiza a USD 103,45. En Racional puedes comprar fracciones, así que no necesitas pagar el precio de una acción completa.

¿Cuánto dinero necesito para invertir en HQY?

Puedes empezar con CLP 5.000. Como Racional permite comprar fracciones de HQY, inviertes el monto que quieras aunque sea menor al precio de una acción.

¿Qué es HQY?

HQY es la acción de HealthEquity, Inc. HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

¿Cuánto ha rentado HQY?

Al 15 de noviembre de 2026, HQY registra +3,96% en el último año, +13,59% en lo que va del año y +53,62% en los últimos 5 años. La rentabilidad pasada no garantiza resultados futuros.

¿Cuánto cuesta invertir en HQY con Racional?

Racional no cobra comisión por transacción ni por mantención en Stocks. La compra de dólares tiene un tipo de cambio de máximo 0,99%, que baja a 0,49% con el plan Pro.